# Evaluation of Two New Innovative Haemostasis Tests: Measurement of the Active Form of GTP-bound Rap1b (aRap1b) in Platelets and the Pro and Antithrombotic Balance of Circulating Endothelial Microvesicles (patEMV) (INNOV-CKD Test)

> **NCT05765630** · NA · UNKNOWN · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 115 (estimated)

## Conditions studied

- Chronic Renal Failure

## Interventions

- **BIOLOGICAL:** BLOOD SAMPLES

## Key facts

- **NCT ID:** NCT05765630
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-08
- **Primary completion:** 2024-03
- **Final completion:** 2024-03
- **Target enrollment:** 115 (ESTIMATED)
- **Last updated:** 2023-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05765630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05765630, "Evaluation of Two New Innovative Haemostasis Tests: Measurement of the Active Form of GTP-bound Rap1b (aRap1b) in Platelets and the Pro and Antithrombotic Balance of Circulating Endothelial Microvesicles (patEMV) (INNOV-CKD Test)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05765630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*